References
- Hosenpud JD, Novick RJ, Bennet LE, et al. The registry of the International Society for Heart and Lung Transplantation: thirteenth official report. J Heart Lung Transplant; 15 1996; 1996: 655–74
- Pesce M, Orlandi A, Capogrossi MC, et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003; 93: 51–62
- Kocher AA, Schuster MD, Wang, et al. Neovascularisation of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430–6
- Stamm C, Westphal B, Steinhoff G, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45–6
- Pompilio G, Cannata A, Pesce M, et al. Long-lasting improvement of myocardial perfusion and chronic refractory angina after autologous intramyocardial PBSC transplantation. Cytotherapy 2005; 7: 494–6
- Ghodsizad A, Klein HM, Borowski A, et al. Intraoperative isolation and processing of BM-derived stem cells. Cytotherapy 2004; 6: 523–6
- Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005; 23: 1128–35
- Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213–26